Literature DB >> 4538534

The effect of residual moisture in lyophilized smallpox vaccine on its stability at different temperatures.

J D Sparkes, P Fenje.   

Abstract

In a study of the influence of residual moisture on the potency of freeze-dried smallpox vaccine, vaccine lots with moisture contents between 0.36% and 6.7% were used. These lots were stored at 4 degrees C, 24 degrees C, and 37 degrees C for up to 6 months, or were exposed to 100 degrees C for up to 3 hours, and were sampled at regular time intervals for assay. No loss in potency occurred at 4 degrees C where the moisture content was 4.8% or less. At 24 degrees C the critical moisture level was 2.5%, and at 37 degrees C it was 0.36%. At 100 degrees C the potency loss was more rapid and there were significant losses after 1 hour at a moisture level of 2.4% or more. A residual moisture content of less than 1% seems to be essential for satisfactory storage of freeze-dried smallpox vaccine.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4538534      PMCID: PMC2480867     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  5 in total

1.  ADVANCES IN THE IMMUNOPROPHYLAXIS OF SMALLPOX.

Authors:  P FENJE
Journal:  Can J Public Health       Date:  1964-08

2.  AN ACCELERATED STORAGE TEST FOR PREDICTING THE STABILITY OF SUSPENSIONS OF MEASLES VIRUS DRIED BY SUBLIMATION IN VACUO.

Authors:  D GREIFF; W A RIGHTSEL
Journal:  J Immunol       Date:  1965-03       Impact factor: 5.422

3.  [Stability and preservability of freeze-dried small-pox vaccine with different moisture contents].

Authors:  M Nomura; C Nishimura; M Kitaoka
Journal:  Jpn J Med Sci Biol       Date:  1965-10

4.  Stabilities of dried suspensions of influenza virus sealed in a vacuum or under different gases.

Authors:  D Greiff; W A Rightsel
Journal:  Appl Microbiol       Date:  1969-06

5.  Stabilities of suspensions of influenza virus dried by sublimation of ice in vacuo to different contents of residual moisture and sealed under different gases.

Authors:  D Greiff
Journal:  Appl Microbiol       Date:  1970-12
  5 in total
  7 in total

1.  Influence of residual moisture and sealing atmosphere on viability of two freeze-dried viral vaccines.

Authors:  P M Precausta; D Simatos; M Le Pemp; B Devaux; F Kato
Journal:  J Clin Microbiol       Date:  1980-10       Impact factor: 5.948

Review 2.  The role of research in viral disease eradication and elimination programs: lessons for malaria eradication.

Authors:  Joel G Breman; Ciro A de Quadros; Walter R Dowdle; William H Foege; Donald A Henderson; T Jacob John; Myron M Levine
Journal:  PLoS Med       Date:  2011-01-25       Impact factor: 11.069

Review 3.  Environmental risk assessment of clinical trials involving modified vaccinia virus Ankara (MVA)-based vectors.

Authors:  Martine Goossens; Katia Pauwels; Nicolas Willemarck; Didier Breyer
Journal:  Curr Gene Ther       Date:  2013-12       Impact factor: 4.391

4.  Live Vaccinia Virus-Coated Microneedle Array Patches for Smallpox Vaccination and Stockpiling.

Authors:  In-Jeong Choi; Hye-Ran Cha; Su Jin Hwang; Seung-Ki Baek; Jae Myun Lee; Seong-O Choi
Journal:  Pharmaceutics       Date:  2021-02-03       Impact factor: 6.321

5.  Povidone-iodine hand wash and hand rub products demonstrated excellent in vitro virucidal efficacy against Ebola virus and modified vaccinia virus Ankara, the new European test virus for enveloped viruses.

Authors:  Maren Eggers; Markus Eickmann; Katharina Kowalski; Juergen Zorn; Karen Reimer
Journal:  BMC Infect Dis       Date:  2015-09-17       Impact factor: 3.090

6.  Rapid and Effective Virucidal Activity of Povidone-Iodine Products Against Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and Modified Vaccinia Virus Ankara (MVA).

Authors:  Maren Eggers; Markus Eickmann; Juergen Zorn
Journal:  Infect Dis Ther       Date:  2015-09-28

Review 7.  Hazard Characterization of Modified Vaccinia Virus Ankara Vector: What Are the Knowledge Gaps?

Authors:  Malachy I Okeke; Arinze S Okoli; Diana Diaz; Collins Offor; Taiwo G Oludotun; Morten Tryland; Thomas Bøhn; Ugo Moens
Journal:  Viruses       Date:  2017-10-29       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.